Latest News from the Labstep team

Our 2022 Round-up is here 💥

Anoä avatar
Shared by Anoä • December 19, 2022

We're so proud of everything we've accomplished this year. So, to nicely wrap up 2022, here’s a round-up of this year’s biggest features – all designed to help you uncover the power of real-time data! ✨

Features:

  • Variables & Conditions – Run protocols and experiments using multiple conditions in parallel.
  • Custom Roles & Permissions – Decide who can do what in the Workspace. Permissions are broken down by entity and action type.
  • Alerts & Reminders – Set alerts on date fields to ensure you never miss an important date.
  • Global Search – Search for content across all your Workspaces all at once.
  • Major Chemistry Upgrades – Add structures from inventory to reaction scheme, match chemicals from reaction scheme to inventory, and search experiments by structure.

UX improvements:

  • New Look Updated Styling and Navigation.
  • Preview Modal – Reduced back-and-forth navigation with preview modal.
  • Right-Hand Side Panel – Reduced modal-in-modal with RHS panel.
  • @ Referencing – Improvements.
  • Filter shortcuts – Improvements.

Thank you for choosing Labstep this year. Have a wonderful holiday season and we'll see you in the new year 🥳

Our full detailed list of features and UX improvements for 2022 is available here.

Team update
News

Labstep, Drug discovery and AI 🔬

Anoä avatar
Shared by Anoä • December 19, 2022

Hi there,

We are delighted to share that Labstep is featured in Business Insider 👏

This is great news for all of us as:

You can read the full article by clicking on the button below ⬇️

New feature
New

Introducing the Conditions Table 🔀

Anoä avatar
Shared by Anoä • December 13, 2022

Hi, our most awaited feature of 2022 is finally here! Have you tried it yet?

You will now be able to run protocols and experiments using multiple conditions in parallel. With our new Conditions table, you can now collect structured data on multiple conditions in just a few clicks.

To learn more, click here.